These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Supplementary studies on Bacterium tularense in laboratory animals. VIII. Immunization experiments on rabbits]. SATO K; OKADA K; KIKUTA K Nihon Saikingaku Zasshi; 1962 Feb; 17():107-11. PubMed ID: 14497417 [No Abstract] [Full Text] [Related]
27. [Characteristics of the tularemia prevention measures in the natural foci of the Carpathian region]. Vetchinin VV; Sukhopiatkina AA; Bat OS; Potapova VG Vrach Delo; 1980 Jan; (1):107-9. PubMed ID: 7376572 [No Abstract] [Full Text] [Related]
28. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination. Fuller CL; Brittingham KC; Hepburn MJ; Martin JW; Petitt PL; Pittman PR; Bavari S J Allergy Clin Immunol; 2006 May; 117(5):1186-8. PubMed ID: 16675351 [No Abstract] [Full Text] [Related]
29. Virulence of Bacterium tularense. I. A study of the virulence of Bacterium tularense in mice, guinea pigs, and rabbits. BELL JF; OWEN CR; LARSON CL J Infect Dis; 1955; 97(2):162-6. PubMed ID: 13263645 [No Abstract] [Full Text] [Related]
30. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine. McMurry JA; Gregory SH; Moise L; Rivera D; Buus S; De Groot AS Vaccine; 2007 Apr; 25(16):3179-91. PubMed ID: 17291638 [TBL] [Abstract][Full Text] [Related]
31. Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac mice. Sunagar R; Kumar S; Franz BJ; Gosselin EJ Vaccine; 2016 Jun; 34(29):3396-404. PubMed ID: 27182819 [TBL] [Abstract][Full Text] [Related]
32. Nature of protective immunity to Francisella tularensis. Tärnvik A Rev Infect Dis; 1989; 11(3):440-51. PubMed ID: 2665002 [TBL] [Abstract][Full Text] [Related]
33. Progress, challenges, and opportunities in Francisella vaccine development. Elkins KL; Kurtz SL; De Pascalis R Expert Rev Vaccines; 2016 Sep; 15(9):1183-96. PubMed ID: 27010448 [TBL] [Abstract][Full Text] [Related]
34. [Association of scarlet fever with vaccination against tularemia]. MARTINEVSKII IL Zh Mikrobiol Epidemiol Immunobiol; 1954 Nov; 11():105-6. PubMed ID: 14349283 [No Abstract] [Full Text] [Related]
35. [Supplementary studies on Bacterium tularense in laboratory animals. VII. Immunization experiments with guinea pigs]. SATO K; OKADA K; KIKUTA K Nihon Saikingaku Zasshi; 1962 Jan; 17():20-7. PubMed ID: 14497416 [No Abstract] [Full Text] [Related]
36. Studies on pathogenesis and immunity in tularemia; immunogenic properties for the white mouse of various strains of Bacterium tularense. DOWNS CM; WOODWARD JM J Immunol; 1949 Oct; 63(2):147-63. PubMed ID: 15390504 [No Abstract] [Full Text] [Related]
37. Activities of Murine Peripheral Blood Lymphocytes Provide Immune Correlates That Predict Francisella tularensis Vaccine Efficacy. De Pascalis R; Mittereder L; Kennett NJ; Elkins KL Infect Immun; 2016 Apr; 84(4):1054-1061. PubMed ID: 26810039 [TBL] [Abstract][Full Text] [Related]